CLINICAL_TRIALS
trial_result
· 2017-06-01
Clinical Trial Update: Oxytocin and Social Cognition in Schizophrenia [Phase 2]
Summary
Phase 2 trial update studying oxytocin's effects on social cognition in schizophrenia; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Maryland, Baltimore | Conditions: Social Cognition, Social Anxiety | Phase 2 | Status: COMPLETED | Results posted: 2017-06-01